Zero-waste clinical supply models may protect margins, but at what cost to patients and data integrity? Lean trials shift risk in ways sponsors cannot afford to ignore.
- U.S. Pharma Tariffs And MFN In 2026: Manufacturing And Procurement Impact
- Beyond The AI Hype: Prompt Engineering In Clinical Trial Supply
- Active Versus Passive Shipping Solutions For Clinical Shipments
- Managing Risk And Resilience In Clinical Trial Supply And Operations
- FDA Staffing Constraints And Operational Risk In Clinical Supply
- Tariffs Threaten Clinical Trial Supply Chains: Preparing For Volatility
- The Key Role Of Clinical Supply Teams In Patient Centricity Efforts
- How Clinical Supply Teams Pull Better Demand Signals
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Compressing Analytical Timelines Without Cutting Corners
Efficient analytical development speeds decisions and improves risk visibility. Using QbD, digital tools, and strong communication helps teams accelerate timelines while maintaining rigor.
-
Addressing Rare Disease Drug Product Manufacturing Challenges
Handling development and manufacturing challenges for orphan drugs requires experience, expertise and scalable technologies, along with a flexible and agile supply chain.
-
Driving Successful Obesity Drug Development With GLP-1 Agonists
GLP-1 agonists are revolutionizing obesity treatment. Signant Health's ePRO solutions support over 30 trials, providing critical patient data and driving successful approvals.
-
Critical Requirements In Sourcing Comparator Drugs
Sourcing comparator drugs has become complex in the clinical supply chain. As a result, clinical trial sponsors and pharma companies are eager to identify opportunities to overcome these challenges.
-
Key Considerations For Emerging Companies When Selecting Packaging Components
Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.
-
The Patient-Centric Clinical Supply Chain For Cell And Gene Therapies
This article explores how delivering cell and gene therapies to patients requires new levels of agility, flexibility and innovation in the logistical management of supply.
-
Practical Playbook For The Manual Assembly Of Combination Products
Manual assembly plays a vital role in early‑phase combination product development. Learn how strong process design, collaboration, and quality controls help teams reduce risk, improve consistency, and move confidently toward later‑stage manufacturing.
-
Providing Drug Supply Support In Complex Environments Through IRT
Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.
-
RTSM/IRT In Clinical Trials: The Complete Guide
RTSM/IRT systems are essential to modern clinical trials. This guide explores how to implement and optimize them to boost efficiency, streamline operations, uphold study integrity, and ensure compliance.
-
Why Advanced cGMP Manufacturing Is Key to Pharma Success
Advanced cGMP facilities deliver control, expertise, and reliable processes that protect quality and support smooth progress to market. Strong partnerships help reduce risk in complex programs.
CATALENT CORNER
| Insights from Catalent's Clinical Supply Experts |
SPONSORED CONTENT
Impact Of Supplier Choice On APAC Clinical Trial Execution
Learn about strategies Asia-Pacific has become an increasingly complex and congested destination for clinical trials as local and global sponsors alike flock to the region to take advantage of its many benefits, including access to large patient pools. Choosing the right clinical packaging and supply chain partner to support these studies is critical and can vary significantly based upon what countries are involved and the types of services required.